Marketing authorization of a new medicinal product is a critical step in giving patients access to innovative therapies. Before and during the marketing authorization procedure, pharmaceutical companies have various opportunities to discuss critical issues in the drug development process with regulators.

In this webinar, Dr Roz Cox shares her perspective of the possible opportunities for interacting with the European, and the UK regulatory agencies, and how to make the most of these opportunities